Publicação científica trimestral do CREMERJ - volume 3 - número 1 - 2024

72 Denervação Simpática Renal no tratamento da Hipertensão Arterial Não Controlada Esmeralci Ferreira e Valerio Fuks Med. Ciên. e Arte , Rio de Janeiro, v.3, n.1, p.60-73, jan-abr 2024 21. Fengler K, Rommel KP, Blazek S, von Roeder M, Besler C, Hartung P, Desch S, Thiele H, Lurz P. Predictors for profound blood pressure response in patients undergoing renal sympathetic denervation. J Hypertens. 2018 Jul;36(7):1578-1584. doi: 10.1097/HJH.0000000000001739. PMID: 29652730. 22. Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension 2011; 57:911. 23. Symplicity HTN-2 Investigators.Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010 Dec 4;376(9756):1903-9. 24. Petidis K, Anyfanti P, Doumas M. Response to Renal Sympathetic Denervation: Renal Function Concerns. Hypertension. 2011 Oct;58(4):e19; author reply e20. Epub 2011 Aug 22. 25. Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT et al for the SYMPLICITY HTN-3 Investigators. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014 Apr 10;370(15):1393-401. 26. Bohm M, Mahfoud F, Ukena C, Hoppe UC, Narkiewicz K, Negoita M eta al. GSR Investigators. First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertension. Hypertension 2015; 65:766-774. 27. Mahfoud F, Bakris G, Bhatt DL, Esler M, Ewen S, Fahy M et al. Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the Global SYMPLICITY Registry. Eur Heart J 2017; 38: 93-100. 28. Völz S, Spaak J, Elf J, Jägrén C, Lundin C, Stenborg A, et al. Renal sympathetic denervation in Sweden: a report from the Swedish registry for renal denervation. J Hypertens. 2018; 36:151-158. [PubMed: 29210862] 29. Böhm M, Mahfoud F, Ukena C, Hoppe UC, Narkiewicz K, Negoita M, et al. First report of the global SYMPLICITY registry on the effect of renal artery denervation in patients with uncontrolled hypertension. Hypertension. 2015; 65:766-774. [PubMed: 25691618] 30. Sharp AS, Davies JE, Lobo MD, Bent CL, Mark PB, Burchell AE, et al. Renal artery sympathetic denervation: observations from the UK experience. Clin Res Cardiol. 2016; 105:544-552. [PubMed: 26802018] 31. Zweiker D, Lambert T, Steinwender C, Weber T, Suppan M, Brussee H, et al. Effects of renal denervation documented in the Austrian National Multicentre Renal Denervation Registry. PLoS One. 2016; 11:e0161250. [PubMed: 27529426] 32. deJager RL, de Beus E, Beeftink MM, et al. Impact of Medication Adherence on the Effect of Renal Denervation: The SYMPATHY Trial. Hypertension 2017; 69:678. 33. Desch S, Okon T, Heinemann D, et al. Randomized sham-controlled trial of renal sympathetic denervation in mild resistant hypertension. Hypertension 2015; 65:1202. 34. Mathiassen ON, Vase H, Bech JN, et al. Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded 24-h blood pressure-based trial. J Hypertens 2016; 34:1639. 35. Azizi M, Sapoval M, Gosse P, et al. Optimum and stepped care standardised anti hypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomized controlled trial. Lancet 2015; 385:1957. 36. Schlaich MP, Sobotka PA, KrumH, et al. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med 2009; 361:932. 37. Mathiassen ON, Vase H, Bech JN, Christensen KL, Buus NH, Schroeder AP et al. Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded 24-h blood pressure-based trial. J Hypertens 2016;34:1639-1647. 38. Gosse P, Cremer A, Pereira H, Bobrie G, Chatellier G, Chamontin B et al. Twenty-Four-Hour Blood Pressure Monitoring to Predict and Assess Impact of Renal Denervation: The DENERHTN Study (Renal Denervation for Hypertension). Hypertension. 2017 Mar;69(3):494-500. doi: 10.1161/HYPERTENSIONAHA.116.08448. Epub 2017 Jan 23